Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001988800 | SCV002285355 | benign | not provided | 2024-10-23 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003138014 | SCV003816146 | uncertain significance | Developmental and epileptic encephalopathy, 64 | 2020-07-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003289358 | SCV003961300 | uncertain significance | Inborn genetic diseases | 2023-06-13 | criteria provided, single submitter | clinical testing | The c.398A>G (p.N133S) alteration is located in exon 6 (coding exon 4) of the RHOBTB2 gene. This alteration results from a A to G substitution at nucleotide position 398, causing the asparagine (N) at amino acid position 133 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |